Malignant gliomas: old and new systemic treatment approaches

por Mesti, Tanja, Ocvirk, Janja
Publicado 2016

The Five-year KRAS, NRAS and BRAF Analysis Results and Treatment Patterns in Daily Clinical Practice in Slovenia in 1(st) Line Treatment of Metastatic Colorectal (mCRC) Patients wi...

por Mesti, Tanja, Rebersek, Martina, Ocvirk, Janja
Publicado 2023

Vismodegib in Locally Advanced Basal Cell Carcinoma in Slovenia

por Mesti, Tanja, Sever, Maša, Ocvirk, Janja
Publicado 2022

Biomarkers for Outcome in Metastatic Melanoma in First Line Treatment with Immune Checkpoint Inhibitors

por Mesti, Tanja, Grašič Kuhar, Cvetka, Ocvirk, Janja
Publicado 2023

Digital ischemic events related to gemcitabine: Report of two cases and a systematic review

por Kuhar, Cvetka Grasic, Mesti, Tanja, Zakotnik, Branko
Publicado 2010

Molecular Biomarkers and Histological Parameters Impact on Survival and Response to First- Line Systemic Therapy of Metastatic Colorectal Cancer Patients

por Rebersek, Martina, Mesti, Tanja, Boc, Marko, Ocvirk, Janja
Publicado 2019

Adverse Events During Immunotherapy in Slovenian Patients with Metastatic Melanoma Reveal a Positive Correlation with Better Treatment Outcomes

por Mesti, Tanja, Ceplak Mencin, Vid, Mileva Boshkoska, Biljana, Ocvirk, Janja
Publicado 2021

Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience

por Mesti, Tanja, Moltara, Maja Ebert, Boc, Marko, Rebersek, Martina, Ocvirk, Janja
Publicado 2015

The cost of systemic therapy for metastatic colorectal carcinoma in Slovenia: discrepancy analysis between cost and reimbursement

por Mesti, Tanja, Boshkoska, Biljana Mileva, Kos, Mitja, Tekavčič, Metka, Ocvirk, Janja
Publicado 2015

Retrospective Analysis of Treatment-naive Slovenian Patients with Metastatic Melanoma Treated with Pembrolizumab – Real-world Experience

por Hribernik, Nezka, Boc, Marko, Ocvirk, Janja, Knez-Arbeiter, Jasna, Mesti, Tanja, Ignjatovic, Marija, Rebersek, Martina
Publicado 2020

Metabolic Impact of Anti-Angiogenic Agents on U87 Glioma Cells

por Mesti, Tanja, Savarin, Philippe, Triba, Mohamed N., Le Moyec, Laurence, Ocvirk, Janja, Banissi, Claire, Carpentier, Antoine F.
Publicado 2014

Bevacizumab plus chemotherapy in elderly patients with previously untreated metastatic colorectal cancer: single center experience

por Ocvirk, Janja, Moltara, Maja Ebert, Mesti, Tanja, Boc, Marko, Rebersek, Martina, Volk, Neva, Benedik, Jernej, Hlebanja, Zvezdana
Publicado 2016

Choroidal thickening with serous retinal detachment in BRAF/MEK inhibitor-induced uveitis: A case report

por Kiraly, Peter, Groznik, Alenka Lavrič, Valentinčič, Nataša Vidovič, Mekjavić, Polona Jaki, Urbančič, Mojca, Ocvirk, Janja, Mesti, Tanja
Publicado 2022

Nuclear Magnetic Resonance Metabolic Fingerprint of Bevacizumab in Mutant IDH1 Glioma Cells

por Mesti, Tanja, Bouchemal, Nadia, Banissi, Claire, Triba, Mohamed N., Marbeuf-Gueye, Carole, Cemazar, Maja, Moyec, Laurence Le, Carpentier, Antoine F., Savarin, Philippe, Ocvirk, Janja
Publicado 2018

The Prognostic and Predictive Value of Human Gastrointestinal Microbiome and Exosomal mRNA Expression of PD-L1 and IFNγ for Immune Checkpoint Inhibitors Response in Metastatic Mela...

por Erman, Ana, Ignjatović, Marija, Leskovšek, Katja, Miceska, Simona, Lampreht Tratar, Urša, Bošnjak, Maša, Kloboves Prevodnik, Veronika, Čemažar, Maja, Kandolf Sekulovič, Lidija, Avguštin, Gorazd, Ocvirk, Janja, Mesti, Tanja
Publicado 2023